We are live on
!
Find out more
PP
Paloma Partners Portfolio holdings
AUM
$510M
1-Year Est. Return
286.05%
This Fund
S&P 500
This Quarter
Est. Return
+5.02%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.78B
AUM Growth
-$541M
(-13%)
Cap. Flow
-$699M
Cap. Flow
% of AUM
-18.5%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
2,134
New
570
Increased
494
Reduced
496
Closed
467
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$28.7M |
| 2 |
Invesco CurrencyShares Euro Currency Trust
FXE
|
+$23.2M |
| 3 |
Biogen
BIIB
|
+$20.8M |
| 4 |
Nike
NKE
|
+$18.3M |
| 5 |
IBM
IBM
|
+$17.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$48.6M |
| 2 |
JPMorgan Chase
JPM
|
+$47.9M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$46.2M |
| 4 |
TRAK
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
|
+$31.6M |
| 5 |
Kimco Realty
KIM
|
+$26.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.62% |
| 2 | Industrials | 6.54% |
| 3 | Financials | 6.19% |
| 4 | Technology | 6.15% |
| 5 | Consumer Discretionary | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Caterpillar
CAT
$402B
| $3.26M | 0.09% |
47,940
+15,677
| +49% | +$1.1M |
|
202
Jazz Pharmaceuticals
JAZZ
$16B
| $3.25M | 0.09% |
23,082
+20,013
| +652% | +$2.77M |
|
203
Tanger
SKT
$4.8B
| $3.25M | 0.09% |
+99,227
| New | +$3.37M |
|
|
PARA
204
DELISTED
Paramount Global Class B
PARA
| $3.23M | 0.09% |
68,546
-24,091
| -26% | -$1.13M |
|
205
CALL
Pfizer
PFE
$141B
| $3.23M | 0.09% |
105,400
+26,350
| +33% | +$829K |
|
|
SNV
206
DELISTED
Synovus
SNV
| $3.22M | 0.09% |
99,472
+82,962
| +502% | +$2.64M |
|
207
Manulife Financial
MFC
$73.2B
| $3.22M | 0.09% |
+214,714
| New | +$3.46M |
|
208
Texas Instruments
TXN
$255B
| $3.2M | 0.08% |
58,435
+51,187
| +706% | +$2.86M |
|
209
Bristol-Myers Squibb
BMY
$128B
| $3.19M | 0.08% |
46,441
+42,455
| +1,065% | +$2.81M |
|
210
CALL
iShares Russell 2000 ETF
IWM
$80.3B
| $3.15M | 0.08% |
28,000
-1,165,800
| -98% | -$134M |
|
211
PUT
Meta Platforms (Facebook)
META
$1.51T
| $3.14M | 0.08% |
30,000
+18,000
| +150% | +$1.85M |
|
212
TE Connectivity
TEL
$60.2B
| $3.14M | 0.08% |
+48,590
| New | +$3.13M |
|
213
Bausch Health
BHC
$1.67B
| $3.13M | 0.08% |
30,821
+24,942
| +424% | +$2.8M |
|
214
Magna International
MGA
$18.3B
| $3.12M | 0.08% |
+77,012
| New | +$3.58M |
|
|
MDRX
215
DELISTED
Veradigm Inc. Common Stock
MDRX
| $3.12M | 0.08% |
202,917
-100,895
| -33% | -$1.45M |
|
|
WAC
216
DELISTED
Walter Investment Mgt Corp
WAC
| $3.11M | 0.08% |
218,938
| – | – |
|
217
Charles River Laboratories
CRL
$10.8B
| $3.1M | 0.08% |
38,500
+4,804
| +14% | +$346K |
|
|
GRMN
218
Garmin
GRMN
$46.8B
| $3.09M | 0.08% |
+83,118
| New | +$3.02M |
|
219
American Airlines Group
AAL
$9.9B
| $3.09M | 0.08% |
72,886
-41,652
| -36% | -$1.8M |
|
220
General Motors
GM
$78.7B
| $3.08M | 0.08% |
+90,623
| New | +$3.15M |
|
221
Applied Materials
AMAT
$410B
| $3.07M | 0.08% |
164,651
+134,440
| +445% | +$2.33M |
|
222
eBay
EBAY
$50.3B
| $3.07M | 0.08% |
111,568
+78,348
| +236% | +$2.16M |
|
223
Expeditors International
EXPD
$22.4B
| $3.05M | 0.08% |
67,716
+61,896
| +1,064% | +$3M |
|
224
Autodesk
ADSK
$47.7B
| $3.04M | 0.08% |
49,846
+42,347
| +565% | +$2.46M |
|
225
PUT
Alphabet (Google) Class A
GOOGL
$3.99T
| $3.03M | 0.08% |
+78,000
| New | +$2.89M |
|
Similar funds
JF
PWMG
NIEF
HIM
MCA
OA
MC
CTAF
Paloma Partners's Q4 2015 Portfolio in Review
As of Q4 2015, Paloma Partners held 2,134 positions worth $3.78B, down 13% from $4.32B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Paloma Partners withdrew a net $699M in Q4 2015, closing 467 positions and reducing 496 holdings. Its most notable exit was SIGMA - ALDRICH CORP, an estimated $48.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, up from 5.8% a quarter earlier, followed by Industrials and Financials.
Against the trend, Paloma Partners opened a new position in Allergan plc worth $30.1M.
- Paloma Partners's largest Q4 2015 buy was Allergan plc: 96,344 shares worth $30.1M.
- Paloma Partners added most to Biogen in Q4 2015, an estimated $20.8M increase.
- Paloma Partners's biggest Q4 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $46.2M.
- Paloma Partners fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $48.6M.
- Paloma Partners's ten largest holdings make up 26% of its $3.78B portfolio in Q4 2015.
- Paloma Partners opened 570 new positions and closed 467 in Q4 2015.
- Paloma Partners's portfolio value fell 13% quarter-over-quarter to $3.78B.
Based on Paloma Partners's 13F filing for Q4 2015, filed 16 Feb 2016.